Type 2 Diabetes Clinical Trial
Official title:
The Role of Information Technology in the Primary Prevention of Type 2 Diabetes
Type 2 diabetes is a major and increasing problem in India and the UK. In clinical trials it can be prevented in people at high risk by lifestyle intervention. While these trials established the proof of principle, they involved a degree of input from healthcare professionals not feasible outside the trial situation. We hypothesize that diabetes prevention can be achieved at lower cost using personalised feedback via mobile phone, based on information on healthy diet and physical activity habits. We shall develop research protocols and computerized algorithms to test this hypothesis in India for application subsequently in the UK and elsewhere.
Diabetes prevention programmes conducted in various ethnic and racial populations have
conclusively demonstrated that lifestyle modification (LSM) focussed on caloric restriction
and increased physical activity can prevent or postpone the onset of T2DM. The Indian
Diabetes Prevention Programme-1 (IDPP-1) conducted by our group established that LSM is an
effective tool for the primary prevention of T2DM in Asian Indian subjects (1). But the
major hurdle for any clinical trial is to disseminate the intervention principles at a
community level is often proved to be very difficult. The main objective of this prevention
programme is to determine whether individualized messages on LSM (diet and physical
activity) by mobile phone-based message delivery system can help educate and motivate
subjects with a high risk for developing type 2 diabetes to adhere to LSM and thereby
improve glucose tolerance.
Sample selection:
This is a randomized, controlled prospective study, carried out in participants who have
been diagnosed with persistent IGT using the 1999 World Health Organization (WHO) criteria.
Interested participants who fulfilled the inclusion criteria participated in this prevention
programme. Screening was carried out in the work places. The participants were advised not
to do any strenuous work during the screening period. Interested participants, after an
overnight fast of 8 to 12 hours, underwent a capillary blood glucose test 2h PG after an
ingestion of 75G glucose. Among the subjects identified with IGT, those with 2h PG values
>8.9 mmol/l (≥ 160 mg/dl) were invited for a confirmatory OGTT, within a week. During the
2nd GTT, venous blood samples were collected at fasting (0 minute), 30 and 120 minutes after
the glucose intake.Subjects who satisfied the criteria for IGT on both occasions were
recruited for this prevention programme. Randomized was based on the MATLAB 'randperm'
random number generator (MARSAGLIA RANDOM NUMBER generator algorithm).
Recruitment:
Subjects were recruited into two groups:
1. control arm: advised on LSM and the beneficial effects of healthy dietary habits,
weight reduction and increased physical activity at the baseline, 6, 12, 18 and 24
months respectively (standard care advise).
2. Intervention group: receive in addition to the above advise would receive frequent text
messages on general well being and different forms of physical activity and principles
of healthy diet. The frequency and time at which each participant preferred to receive
the messages were noted.
Assessments:
Both groups will undergo personal reviews at 6 monthly intervals for a period of 2 years. At
randomization, participants were interviewed personally to elicit demographic, medical,
diet, behavioral and physical activity details.
6 & 18 month assessments: Diet and physical activity questionnaires, body weight, WC, pulse
and BP will be obtained. Two hour post glucose will be measured.
12 & 24 month assessment: Participants will be questioned about the acceptability of the
project and its impact on their life. Changes in health will be documented and the physical
examination repeated. They will complete further dietary, physical activity and quality of
life questionnaires and will be asked about their use of healthcare resources for health
economic assessment. The OGTT and ECG will be repeated, with other measurements as at
baseline.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |